BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6052803)

  • 1. [Serum thyrotropic hormone (T.S.H.) and the long acting stimulator substance (L.A.T.S.) in hyperthyroidism. Preliminary communication].
    Bonnyns M
    Rev Fr Etud Clin Biol; 1967 Jan; 12(1):77-9. PubMed ID: 6052803
    [No Abstract]   [Full Text] [Related]  

  • 2. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
    Gautier E; Juillard E; Lemarchand-Béraud T
    Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
    [No Abstract]   [Full Text] [Related]  

  • 3. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
    zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
    Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of thyrotropic hormone and long acting thyroid stimulator by the McKenzie technique. Critical study of the method].
    Bonnyns M
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):845-52. PubMed ID: 5709509
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
    Friis T
    Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 7. LATS activity, hyperthyroidism, exophthalmos, pretibial myxoedema and acropachy.
    Bartholomew C
    Br J Clin Pract; 1972 Sep; 26(9):431-3. PubMed ID: 5080337
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hormonogenesis in thyroid neoplasms].
    Valenta L; Lemarchand-Béraud T; Vannotti A; Silink K
    Schweiz Med Wochenschr; 1968 Jan; 98(4):101-10. PubMed ID: 5670492
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pitfalls in the biological demonstration of the "long acting thyroid stimulator" (LATS)].
    Mertz DP; Stelzer M
    Schweiz Med Wochenschr; 1968 Sep; 98(38):1471-5. PubMed ID: 5680881
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fluctuations of the long-acting thyroid stimulator (LATS) concentration in the blood and its significance in hyperthyroidism].
    Noguchi A; Kurihara H; Ozeki Y; Sato S
    Nihon Rinsho; 1967 Oct; 25(8):1723-32. PubMed ID: 5626106
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of iodine administration on the thyrotropic hormone and long-acting thyroid stimulator level in the plasma].
    Földes J; Krasznai I; Piroska E; Gesztesi E; Takács I
    Endokrinologie; 1967; 52(1):80-7. PubMed ID: 4171706
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical significance of LATS and TSH in the blood.
    Lemarchand-Béraud T; Griessen M; Scazziga BR
    Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
    [No Abstract]   [Full Text] [Related]  

  • 13. [The significance of the thyrotropic hormone (TSH), long-acting thyroid stimulator (LATS) and exophthalmos-producing factor (EPF) in various forms of thyroid hyperfunction].
    Horster FA; Schleusener H; Schimmelpfennig K
    Dtsch Med Wochenschr; 1967 Apr; 92(14):673-7. PubMed ID: 5337982
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma thyrotropin (TSH) and long-acting thyroid stimulator (LATS) in patients treated for thyroid carcinoma.
    Valenta L; Lemarchand-Béraud T; Vannotti A
    Eur J Cancer (1965); 1970 Apr; 6(2):139-43. PubMed ID: 5450187
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relation between the exophthalmos producing factor (EPF) and thyroid antibodies].
    Kreysing G; Schemmel K; Weisbecker L; Uthgenannt H; Müller W; Kirmse L
    Schweiz Med Wochenschr; 1968 Jun; 98(23):852-4. PubMed ID: 5666557
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quantitative analysis of serum thyrotropic activity by a biologic method].
    Decoulx M; Racadot A; Fossati P; Linquette M
    Lille Med; 1968 Nov; 13(9):971-8. PubMed ID: 4907357
    [No Abstract]   [Full Text] [Related]  

  • 17. [Etiopathogenesis of thyrotoxicosis].
    de Medeiros Neto GA
    Rev Paul Med; 1967 Jan; 70(1):48-52. PubMed ID: 5631892
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of the "long acting thyroid stimulator"].
    Tourneur R; Letonturier P; Sénécal P
    Cah Med; 1974 Mar; 15(3):121-3. PubMed ID: 4479615
    [No Abstract]   [Full Text] [Related]  

  • 19. CLINICAL STUDIES ON THE LONG-ACTING THYROID STIMULATOR.
    NOGUCHI A; KURIHARA H; SATO S
    J Clin Endocrinol Metab; 1964 Feb; 24():160-5. PubMed ID: 14123839
    [No Abstract]   [Full Text] [Related]  

  • 20. Neonatal hyperthyroidism and long-acting thyroid stimulator protector.
    Nutt J; Clark F; Welch RG; Hall R
    Br Med J; 1974 Dec; 4(5946):695-6. PubMed ID: 4479947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.